MedPath

Assessing the effect of Katphala in the management of Prameha (Type 2 Diabetes Mellitus)

Phase 3
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/06/069464
Lead Sponsor
Post Graduate Institute of Ayurveda DSRRAU Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients between the age group of 30-70 years of either sex present with clinical

features of Prameha. 2. Patients having a fasting blood sugar level (FBS) greater than 126 mg/dL and less than 200 mg/dL. 3. Patients having a 2 hour post prandial blood sugar level (PPBS) greater than 200 mg/dL and less than 350 mg/dL. 4. Written consent showing willingness to participate in the study.

Exclusion Criteria

1. Patients below 30 years and above 70 years will be excluded. 2. Pregnant and lactation mothers. 3. Known case of Type 1 Diabetes Mellitus or I. D. D. M. Patients. 4. Type 2 DM patients having insulin therapy due to secondary failure. 5. Patients suffering from the complications of DM like Ketoacidosis, Neuropathy, Nephropathy, Retinopathy and Diabetic wounds. 6. Patients suffering from any severe systemic disease, chronic infections or any active malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Fasting Blood Sugar and Post Prandial Blood SugarTimepoint: 60 DAYS
Secondary Outcome Measures
NameTimeMethod
Changes in Glycosylated Haemoglobin (HbA1c)Timepoint: 60 DAYS
© Copyright 2025. All Rights Reserved by MedPath